第三者割当による無担保転換社債型新株予約権付社債並びに新株予約権の月間行使状況に関するお知らせ 

Gene Techno Science Co., Ltd. is a biomedicine company that researches and developes drugs. In addition to drug development, the company also supply the pharmaceutical ingredients.

営業外費用（支払利息及び株式交付費）の計上に関するお知らせ

2022年3月期 第2四半期決算短信〔日本基準〕（連結）

2022年3月期 第2四半期決算短信 補足説明資料

Japan

TRANS GENIC INC. develops, produces, and sells specific idiotype bearing antibody (bio reagent).  The Company also develops mutant mice and sells mice' genetic function analysis data.

D.Western Therapeutics Institute Inc.(DWTI) is a biotechnology (bio-venture) company that focuses on development of new drugs. The Company's focus is on protein kinase inhibitors. DWTI discovers and develops several drugs, such as antiglaucoma, antihypertensive, neuroprotective, antithrombogenic, antiatherosclerosis and anticancer.

D.Western Therapeutics Institute Inc. (4576 JP)

Ribomic, Inc. develops ribonucleic acids (RNA) called aptamers. The company conduct research and develops new medication based on Ribomic Aptamer Refined Th erapeutics System. The company also conduct advisory to pharmaceutical companies and product licensing.

AnGes MG, Inc. develops gene-therapy drugs that use Hepatocyte Growth Factor (HGF) for myocardial infarction and arteriosclerosis patients.  The Company also develops nucleic acid drug (decoy oligo) for patients with asthma, allergy, and rheumatism.  AnGes MG develops vectors (a carrier used to introduce a foreign gene into a host cell) which help study and analyze genetic functions.

CanBas Company Ltd. is a biopharmaceutical company that develops anti-cancer drugs with fewer side effects.  The Company's core technologies include drugs that target the G2 checkpoint and a screening system to find selective abrogators of the G2 checkpoint.

Oncolys BioPharma Inc. provides pharmaceutical and diagnostic products and services.. The Company researches, develops, manufactures and sells drugs targeting cancer and serious infectious diseases and also provides inspection services for viruses.

3-D Matrix, Ltd. researches and develops medical products by applying self assembling peptide technology.

OncoTherapy Science Inc., is a biopharmaceutical company. The Company conducts research & development of medicine, treatments, and gene-analysis on cancer.

ReproCell Incorporated develops iPS (Induced Pluripotent Stem Cell) business and clinical examination for organ transplantation based on human iPS and ES (Embryonic Stem Cell) technology.

NanoCarrier Co., Ltd. is a biotech company that utilizes micellar nanoparticle (polymeric micelles) technology for the production and development of pharmaceuticals focusing mainly on cancer therapies.

Cynata Therapeutics Ltd is involved in regenerative medicine.  The Company is focused on the commercialization of a stem cell platform.

Genematrix Inc. provides diagnostics & therapeutic solution.  The Company's services are based on Restriction Fragment Mass Polymorphism (RFMP) technology and applied to theranostics, prognosis, and molecular diagnosis.

China Regenerative Medicine International Limited is engaged in research and development of bio-medical and healthcare products, and medical techniques, the provision of the production and sales of tissue engineering products and its related by-products, as well as sales and distribution of medical products and equipment.

General Biologicals Corp. produces molecular diagnostic product. The Company's also offer research development, marketing and servicing of products and solutions for hospitals, medical laboratory and blood bank, and research and industry.

DNA Link Inc. is a biotechnology company specializing in genomic research technology for rapid analysis of whole genomes.  The Company also provides personalized genomic service which analyze individual's genomic sequence to identify his or her susceptibility to genetic diseases and calculate their risk factors.

Daesung Microbiological Labs Co., Ltd. develops and manufactures canine, poultry, swine, and bovine drugs and vaccines.  The Company's products have applications for increasing immunity and preventing epidemic for livestock. Daesung Microbiological Labs also researches microorganism for ocean and soil improvement purposes.

DR. Chip Biotechnology Inc. develops biochips, nucleic acid extraction kits, rapid hybridization equipment, biotechnology software, as well as provides diagnostic services.

vTv Therapeutics Inc. operates as a clinical-stage pharmaceutical company. The Company focuses on the discovery and development of human therapeutics to fill unmet medical needs. vTv Therapeutics serves customers in the United States.

Alaunos Therapeutics Inc. operates as a clinical stage cellular immuno-oncology company. The Company focuses on the treatment of solid tumors through adoptive TCR-T cell therapy. Alaunos Therapeutics serves customers worldwide.

Original BioMedicals Co., Ltd. is a biotechnology company. The Company develops new drugs and creates drug carriers to enhance or repurpose current drugs.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Gene Techno Science (4584 JP)

第三者割当による無担保転換社債型新株予約権付社債並びに新株予約権の月間行使状況に関するお知らせ

営業外費用（支払利息及び株式交付費）の計上に関するお知らせ

2022年3月期第2四半期決算短信〔日本基準〕（連結）

2022年3月期第2四半期決算短信補足説明資料

第三者割当による無担保転換社債型新株予約権付社債並びに新株予約権の月間行使状況に関するお知らせ

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

第三者割当による無担保転換社債型新株予約権付社債並びに新株予約権の月間行使状況に関するお知らせ

営業外費用（支払利息及び株式交付費）の計上に関するお知らせ

2022年3月期 第2四半期決算短信〔日本基準〕（連結）

2022年3月期 第2四半期決算短信 補足説明資料

第三者割当による無担保転換社債型新株予約権付社債並びに新株予約権の月間行使状況に関するお知らせ

2022年3月期第2四半期決算短信〔日本基準〕（連結）

2022年3月期第2四半期決算短信補足説明資料